Teplizumab Induces Human Gut-Tropic Regulatory Cells in Humanized Mice and Patients
Author:
Affiliation:
1. Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
2. Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Abstract
Publisher
American Association for the Advancement of Science (AAAS)
Subject
General Medicine
Reference38 articles.
1. Anti-TNF Therapy, from Rationale to Standard of Care: What Lessons Has It Taught Us?
2. Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis
3. A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
4. Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
5. Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes
Cited by 72 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The immunology of type 1 diabetes;Nature Reviews Immunology;2024-02-02
2. The beta cell-immune cell interface in type 1 diabetes (T1D);Molecular Metabolism;2023-12
3. Immune responses to gut bacteria associated with time to diagnosis and clinical response to T cell–directed therapy for type 1 diabetes prevention;Science Translational Medicine;2023-10-25
4. A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab;Diabetologia;2023-10-02
5. Therapeutic Antibodies in Medicine;Molecules;2023-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3